Skip to main content
. 2019 Jul 29;14:5943–5955. doi: 10.2147/IJN.S214521

Figure 2.

Figure 2

Schematic principle of how lysostaphin conjugated with liposomal vancomycin bind to MRSA cell wall. Binding of lysostaphin molecules to pentaglycine cross-bridges of the peptidoglycan leads to disruption of MRSA cell wall while, the release of vancomycin from the liposomes occurs, which subsequently kills or inhibits the growth of the bacteria.